Evidence map›Paper›PMID 37591723›Full record

ArticleLife science alliance2023

Whole genome sequencing of drug resistance

Tao Shi, Fenyong Shou, Ying He, Kan Zhou, Wenwan Gao, Xiaoping Nie, Mei Han, Chuanyu Liao, Tongxin Li

Open access · goldAbstract read
In one paragraph

Article in Life science alliance, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Comparison of characteristics of drug-resistantJournal of family medicine and primary care · 2026
    Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Tao ShiDepartment of Orthopedics, Tianjin First Central Hospital, Tianjin, China shitaostone@163.com.ORCID 0000-0002-8216-2542
Fenyong ShouDepartment of Orthopedics, Tianjin First Central Hospital, Tianjin, China.
Ying HeCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Kan ZhouCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Wenwan GaoCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Xiaoping NieMedical Department, Chongqing Public Health Medical Center, Chongqing, China.
Mei HanCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China.
Chuanyu LiaoCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China 542341136@qq.com.ORCID 0009-0006-0649-0065
Tongxin LiCentral Laboratory, Chongqing Public Health Medical Center, Chongqing, China cqltxin@163.com.ORCID 0000-0003-0010-4355
Chongqing Public Health Medical Center · CNTianjin First Center Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to determinate characteristics of drug resistance

Indexed as

Mycobacterium tuberculosisTuberculosis, ExtrapulmonaryTuberculosis, Multidrug-ResistantDrug ResistanceHumansRetrospective StudiesRifampinWhole Genome SequencingRifampin

Identifiers

PMID37591723
PMCPMC10435967
OpenAlexW4385968484

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.